Multiple myeloma
Dana-Farber Cancer Institute · National Center for Tumor Diseases · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
694
total citations
- FWCI
- 28.33
- Percentile
- 100%
- References
- 148
Citations per year
Authors
5- MSMarc S. Raab
Dana-Farber Cancer Institute, National Center for Tumor Diseases, Heidelberg University, German Cancer Research Center
- KPKlaus Podar
Dana-Farber Cancer Institute
- IBIris Breitkreutz
National Center for Tumor Diseases, German Cancer Research Center, Heidelberg University, Dana-Farber Cancer Institute
- PGPaul G. Richardson
Dana-Farber Cancer Institute
- KCKenneth C. AndersonCorresponding
Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Multiple myeloma
- Thalidomide
- Lenalidomide
- Bortezomib
- Medicine
- Bone marrow
- Oncology
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.